Picture of Dermata Therapeutics logo

DRMA — Dermata Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Dermata Therapeutics Inc - On April 20, Co Entered Into A Securities Purchase Agreement With An Institutional Investor

April 25 (Reuters) - Dermata Therapeutics Inc  DRMA.O :
    * DERMATA THERAPEUTICS INC - ON APRIL 20, CO ENTERED INTO A
SECURITIES PURCHASE AGREEMENT WITH AN INSTITUTIONAL INVESTOR
    * DERMATA THERAPEUTICS INC - PURCHASE PRICE PER SHARE AND
ASSOCIATED COMMON STOCK WARRANT WAS $1.325
    * DERMATA THERAPEUTICS INC - PURCHASE PRICE PER PRE FUNDED
WARRANT
AND ASSOCIATED COMMON STOCK WARRANT WAS $1.3249
    * DERMATA THERAPEUTICS INC - EACH COMMON STOCK WARRANT
ENTITLES
HOLDER TO PURCHASE ONE SHARE OF COMMON STOCK AT AN EXERCISE
PRICE OF $1.325 PER SHARE
    * DERMATA THERAPEUTICS INC - PRIVATE PLACEMENT CLOSED ON
APRIL 25

Further company coverage:  DRMA.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Dermata Therapeutics

See all news